Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Calcium antagonists and heart failure.

S Charlap1, W H Frishman

  • 1SUNY Health Science Center, Brooklyn, New York.

The Medical Clinics of North America
|March 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

AIDS and the heart: Clinicopathologic assessment.

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology·2015
Same author

ACE inhibitors and the arterial wall. Introduction.

Postgraduate medicine·2009
Same author

Pathophysiology and medical management of systemic hypertension and pre-eclampsia in pregnancy.

Minerva medica·2006
Same author

Antiplatelet therapy: glycoprotein IIb/IIIa receptor antagonists.

Drugs of today (Barcelona, Spain : 1998)·2003
Same author

Alcohol as a cardioprotective agent.

Heart disease (Hagerstown, Md.)·2002
Same author

Cardiopulmonary resuscitation 2000.

Heart disease (Hagerstown, Md.)·2002

Calcium antagonists, used for reducing afterload in heart failure, have limited use due to their negative inotropic effects on the heart. These vasodilators may not be ideal for treating patients with left ventricular failure.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Calcium antagonists possess vasodilatory properties beneficial for reducing afterload in left ventricular failure.
  • Unlike other vasodilators, calcium antagonists directly impact myocardial contractility negatively.

Purpose of the Study:

  • To evaluate the potential role of calcium antagonists as afterload-reducing agents in patients experiencing left ventricular failure.

Main Methods:

  • Review of clinical data and pharmacological actions of calcium antagonists.
  • Analysis of their effects on systemic vasodilation and myocardial contractility.

Main Results:

  • Calcium antagonists demonstrate systemic vasodilatory actions.
  • A significant negative inotropic effect on the myocardium was observed, differentiating them from other vasodilators.

Related Experiment Videos

Conclusions:

  • Clinical evidence indicates a restricted application for calcium antagonists in vasodilator therapy for heart failure patients.
  • The direct negative inotropic effect limits their therapeutic utility in managing left ventricular failure.